http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1383431-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-65611
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-65613
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D499-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D499-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6561
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D499-18
filingDate 1972-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1974-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-1383431-A
titleOfInvention Pentavalent phosphorus amides of cephalosporins
abstract 1383431 Phosphorus amides of cephalosporins ELI LILLY & CO 10 Jan 1972 [11 Jan 1971] 1095/72 Headings C2C and C2P Novel phosphorus amides of cephalosporins, having the general Formula (I) wherein each of R 1 and R 2 is a C 1-15 hydrocarbon 'or O-hydrocarbon radical which is free of aliphatic unsaturation; m is 1, 2 or 3; R 3 is -H or -OCH 3 ; R 4 is a group of formula in which R 5 is hydrogen, an alkali metal cation, an ammonium or amine cation, a negative charge or an ester group, and R 6 is hydrogen, O-(C 1-4 alkyl), S-(C 1-4 alkyl), where n and m are independently 1, 2 or 3, pyridyl, amino-pyridyl, where R 1 and R 2 are as defined above, or and Y is a group of formula in which M is H, an alkali metal cation or a group forming a C 1-4 alkyl mixed carbonic anhydride with the carboxylic group; R 10 is NH 2 or NH 3 <SP>(+)</SP>, or may be hydrogen when there is an amino group in another part of Y or the group R 4 , and the phenyl ring may be substituted with Cl, OH, NH 2 , #-amino-C 2-3 alkyl or NO 2 ; and cyclohexylamine salts thereof, are prepared by reacting a phosphorus compound of formula with a primary amino group-containing cephalosporin of Formula (II) wherein R 1 , R 2 , R 3 , R 4 and Y are as defined above and X is Cl or Br, in a liquid reaction medium at a pH of 7À5 to 12. The phosphorus amides may be decomposed to give the cephalosporin starting material (II) by allowing to stand in solution in cyclohexanone, when the said cephalosporin precipitates. This property provides a further aspect of the invention whereby cephalosporins of Formula (II) may be recovered from their impure solutions by conversion to the phosphorus amide (I) by the reaction described above, extracting with cyclohexanone and allowing the extract to stand at room temperature to precipitate the original cephalosporin (II). Alternatively, the cyclohexanone solution may be treated with cyclohexylamine to precipitate the cyclohexylamine salt of the cephalosporin phosphorus amide. This salt may be subjected to a conventional de-amidation procedure (e.g. reaction with PCl 5 , then methanol followed by hydrolysis) to give 7-aminocephalosporanic acid.
priorityDate 1971-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID223
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419518845
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457698762
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7965
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419489307
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559564
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409210383
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID280
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7058093
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7967

Total number of triples: 33.